Hepatitis B Virus
Hepatitis B virus replication is efficiently inhibited by small interfering RNAs
Published in Gene Therapy Weekly, August 24th, 2006
"HBV, as a major cause of acute and chronic hepatitis in humans, contains a partial double-stranded circular DNA genome of 3.2 kb that is transcribed into the 3.5-, 2.4-, 2.1-, and 0.7-kb viral transcripts by the host RNA polymerase II. The HBV X (HBx) gene is consistently expressed in all four HBV viral mRNAs and is thus an ideal target for developing viral inhibitors via a gene therapeutic approach.
"In this study, we show that two HBx-specific small interfering RNAs (siRNA),...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-08-24)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Proliferation of esophageal cancer cells promoted by differentiation inhibitor - Cancer Therapy
Ganglioside modulates tumor suppressor-mediated transcriptional induction - Glioblastoma
Telomerase inhibition impairs tumor growth in glioblastoma xenografts - Ophthalmology
Effects of retrotransposon insertion on photoreceptor transcription clarified - Allergy & Immunology
Aspergillus-sensitized early airway response inhibited by a surfactant protein - Angiology
Venous thrombosis risk increased by hemostatic protein nonsense polymorphism - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
